baber/WOPTO huggingface dataset:
Patent AU-2016252738-B2 (AU)
Title: Glucose-responsive insulin delivery system using hypoxia-sensitive nanocomposites
Inventor: GU ZHEN
IPC: A61K9/51
Filed: 2016-04-21
Granted: 2021-07-08
Abstract: A closed-loop insulin delivery system is described. More particularly, the presently disclosed insulin delivery system can comprise glucose-responsive vesicles that release insulin in response to hypoxia triggered by enzymatic reduction of glucose. In addition or as an alternative to insulin, the delivery system can release other diabetes treatment agents, such as non-insulin-based diabetes treatment agents. The vesicles can be prepared from a hypoxia sensitive polymer, such as a hypoxia-sensitive hyaluronic acid (HS-HA). The HS-HA can comprise hydrophobic groups that can be reduced in hypoxic environments to form hydrophilic groups. The vesicles can be loaded into microneedles and microneedle array patches for use in the treatment of diabetes or to otherwise regulate blood glucose levels in subjects in need of such treatment.
Patent AU-2016253635-B2 (AU)
Title: Cordless hand-held ultrasonic cautery cutting device
Inventor: SMITH KEVIN W
IPC: A61B17/00
Filed: 2016-11-03
Granted: 2018-04-05
Abstract: CORDLESS HAND-HELD ULTRASONIC CAUTERY CUTTING DEVICE An ultrasonic surgical assembly, comprising: a surgical handle (2300) including a first handle body portion defining an aseptically sealable battery-holding compartment and a second handle body portion connected to the first handle body portion; a waveguide (2504) supported by and extending distally from the second handle body portion; a cordless ultrasonic generator (2404) supported by the second handle body portion, the cordless ultrasonic generator including a driving-wave generation circuit; a cordless ultrasonic transducer (2406) supported by the second handle body portion, the cordless ultrasonic transducer (2406) coupled to the driving wave generation circuit and having an output couple connected to the waveguide (2504), the cordless ultrasonic transducer (2406) configured to dynamically produce a resonant wave along the waveguide (2504); and a battery (3902), wherein the first handle body portion is configured to removably hold the battery within the aseptically sealable battery-holding compartment, and wherein the surgical handle is configured to electrically connect the battery with the cordless ultrasonic generator when the battery is disposed within the battery-holding compartment.
Patent AU-2016303000-B2 (AU)
Title: Nutritional compositions with 2FL and LNnT for use in inducing a gut microbiota close to the one of breast fed infants
Inventor: BERGER BERNARD
IPC: A61K31/7028
Filed: 2016-08-04
Granted: 2021-01-21
Abstract: The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide for promoting or inducing a global gut microbiota that is closer to the one of infants fed exclusively with human breast milk, in comparison to infants fed with a conventional nutritional composition. The composition can be an infant formula and is in particular intended for infants between 0 and 12 months of age fed predominantly with infant formula. It promotes a healthy intestinal flora and has beneficial short and long terms effects.
Patent AU-2016312597-B2 (AU)
Title: EFP detonating cord
Inventor: GEERTS SHAUN M
IPC: F42B3/08
Filed: 2016-08-25
Granted: 2019-06-20
Abstract: A perforating tool (100) includes an encapsulated shaped charge (10) that has a bulkhead (26) with a reduced wall thickness section (34), a plate (55) having a shallow recess, and a detonating cord (50) having an energetic core (52). The energetic core forms the plate into an explosively formed perforator when detonated. The plate is positioned to direct the explosively formed perforator into the reduced wall thickness section.
Patent AU-2016340028-B2 (AU)
Title: Vehicle parking or vehicle use in a chargeable area
Inventor: EDWARDS JOHN
IPC: G07B15/00
Filed: 2016-10-12
Granted: 2020-04-09
Abstract: A system (1, 401), monitoring device (5, 405) and computer implemented method to account for parking of a vehicle (3, 403) in a chargeable parking area (4, 404) or use of a vehicle (3, 403) in a toll area (406). The monitoring device (5, 405) is associated with the vehicle (3, 403) and may have one or more electronic circuits operable in a low power mode and a high power mode. A user input (19) may be associated with the monitoring device (5, 405) so that a user can confirm or deny that the vehicle (3, 403) is parked, or should be charged for parking in the chargeable parking area (4, 404), or should be charged for use of a vehicle in the toll area (406).
Patent AU-2016374661-B2 (AU)
Title: Recovery of lithium from silicate minerals
Inventor: HUNWICK RICHARD
IPC: C22B3/06
Filed: 2016-12-22
Granted: 2020-04-09
Abstract: A process and system are disclosed for recovering lithium from a lithium-containing silicate mineral. The process and system comprise mixing the silicate mineral with nitric acid. The process and system also comprise subjecting the mixture to a leaching process having conditions such that lithium values in the silicate mineral are leached from the silicate mineral as lithium nitrate. The nitric acid can be in aqueous, gaseous or precursor gaseous form.
Patent AU-2016375443-B2 (AU)
Title: Wringing device for a mop
Inventor: BRUGORA ALESSANDRO
IPC: A47L13/58
Filed: 2016-12-19
Granted: 2019-10-10
Abstract: The invention relates to a wringing device (1) for a mop, comprising a basket-like receiving portion (2) in which said mop can be wrung out by pressing, and a retainer (3) for securing the wringing device (1) in a mop bucket. Said receiving portion (2) is guided in the retainer (3) such that it can move translationally in the direction of insertion of the mop.
Patent AU-2016385454-B2 (AU)
Title: Operating multi-modal medicine delivery systems
Inventor: MAZLISH BRYAN
IPC: G16H10/00
Filed: 2016-12-20
Granted: 2021-12-16
Abstract: Some embodiments a multi-modal medicine delivery system can be configured to control dispensation of medicine according to any of a plurality of delivery modes, such as closed-loop delivery modes and open-loop delivery modes, and according to a secondary feedback loop to determine user-specific settings related to dosage delivery.
Patent AU-2016434431-B2 (AU)
Title: Mattress assembly with a mattress topper that includes pocketed coil springs and methods of producing the same
Inventor: DEMOSS LARRY K
IPC: A47C27/12
Filed: 2016-12-29
Granted: 2023-02-02
Abstract: A mattress assembly is provided that includes a mattress core having a bottom surface and a top surface opposite the bottom surface, and a mattress topper positioned adjacent to the top surface of the mattress core. The mattress topper includes a plurality of coil springs, an upper fabric layer extending above the plurality of coil springs, and a lower fabric layer extending below the plurality of coil springs. The lower fabric layer is connected to the upper fabric layer around each coil spring such that the upper fabric layer and the lower fabric layer collectively form a fabric pocket encasing each coil spring. The mattress topper further includes a padded layer positioned atop the upper fabric layer, with the padded layer connected to the upper fabric layer by ultrasonic welds and/or tufts. Methods of producing a mattress topper for connection to a mattress core are further provided.
Patent AU-2017204049-B2 (AU)
Title: Heavy metal capture mass with improved performances
Inventor: BARTHELET KARIN
IPC: B01J20/28
Filed: 2017-06-15
Granted: 2021-09-09
Abstract: A capture mass for heavy metals, in particular mercury, contained in a gaseous or 
liquid feed, said mass comprising: 
- copper which is present at least in part in the sulphide form, CuxSy; 
- a porous support based on alumina; 
characterized in that said porous support has a total pore volume (TPV) in the range 0.8 to 
1.5 cm 3/g, a mesopore volume (V6nm-loom) in the range 0.5 to 1.3 cm 3/g, and a macropore 
volume (Vioom) in the range 0.33 to 0.45 cm 3/g, 
it being understood that the ratio between the mesopore volume and the macropore volume 
(V6nm-Ioonm / Viom) is in the range 1 to 5.
Patent AU-2017220032-B2 (AU)
Title: User interface for a cooking system
Inventor: VENGROFF DARREN ERIK
IPC: G05B15/00
Filed: 2017-02-17
Granted: 2019-06-27
Abstract: According to one example, a system includes a heat source operable to provide an amount of energy to be used to cook a food item in accordance with a cooking recipe. The system further includes a processor operable to receive, via a first communication link with a wireless device, an indication of a first temperature associated with the cooking recipe. The processor is further operable to, based on the indication of the first temperature, adjust the amount of energy provided by the heat source. The processor is further operable to send, to a user interface system, an indication of the adjusted amount of energy provided by the heat source. The system further includes a user interface system that includes an array of light source systems operable to provide a visual representation of the adjusted amount of energy, and a touch sensor.
Patent AU-2017288910-B2 (AU)
Title: Microstructured packaging surfaces for enhanced grip
Inventor: HULSEMAN RALPH ALLEN
IPC: B29C59/02
Filed: 2017-06-23
Granted: 2023-03-09
Abstract: A label with improved physical properties comprising: a base layer having a microstructured area; a composite microstructure having a first, second and third set of microstructures disposed on the microstructured area; a dry lift force attributable to the composite microstructure greater than 7 pounds according to lift testing; a wet lift force attributable to the composite microstructure greater than 7 pounds according to lift testing; an adhesive layer affixed to the base layer for affixing the label to a container; and, thereby providing a microstructured label having improved gripping physical properties that can be affixed to a container.
Patent AU-2017306302-B2 (AU)
Title: Method and apparatus for threat identification through analysis of communications signaling, events, and participants
Inventor: DOUGLAS LANCE
IPC: H04M3/22
Filed: 2017-08-02
Granted: 2019-03-28
Abstract: Aspects of the invention determining a threat score of a call traversing a telecommunications network by leveraging the signaling used to originate, propagate and terminate the call. Outer-edge data utilized to originate the call may be analyzed against historical, or third party real-time data to determine the propensity of calls originating from those facilities to be categorized as a threat. Storing the outer edge data before the call is sent over the communications network permits such data to be preserved and not subjected to manipulations during traversal of the communications network. This allows identification of threat attempts based on the outer edge data from origination facilities, thereby allowing isolation of a compromised network facility that may or may not be known to be compromised by its respective network owner. Other aspects utilize inner edge data from an intermediate node of the communications network which may be analyzed against other inner edge data from other intermediate nodes and/or outer edge data.
Patent AU-2017318661-B2 (AU)
Title: Collection probe and methods for the use thereof
Inventor: EBERLIN LIVIA SCHIAVINATO
IPC: H01J49/00
Filed: 2017-08-31
Granted: 2022-01-27
Abstract: Method and devices are provided for assessing tissue samples from a plurality of tissue sites in a subject using molecular analysis. In certain aspects, devices of the embodiments allow for the collection of liquid tissue samples and delivery of the samples for mass spectrometry analysis.
Patent AU-2017325870-B2 (AU)
Title: Tetrahydroisoquinoline kappa opioid antagonists
Inventor: CARROLL FRANK IVY
IPC: A61K31/4725
Filed: 2017-09-15
Granted: 2021-07-22
Abstract: Potent opioid receptor antagonists of formula (I) and their use as pharmacotherapies for treating depression, anxiety, schizophrenia, eating disorders, and addiction to cocaine, methamphetamine, nicotine, alcohol, and opiates are disclosed. More specifically, the disclosure provides potent and selective kappa opioid receptor antagonist compounds, pharmaceutical compositions of those compounds and uses of those compounds to ameliorate or treat addictions, eating disorders, etc.
Patent AU-2017370545-B2 (AU)
Title: Dehider regulator valve
Inventor: GRINASKI TIMOTHY
IPC: G05D16/00
Filed: 2017-12-01
Granted: 2020-08-13
Abstract: An air pressure regulator for a dehider includes a valve to open and close the flow of pressurized air in an air inlet, a first spring urging the valve in the direction of air flow through the inlet to close the valve, a plunger operable to move the valve from a closed to an open position against the direction of air flow, a piston connected to the valve exposed to the air flow, and a second spring between the piston and the plunger. Upon depressing the plunger, the second spring urges the piston to open the valve against the air flow direction to permit pressurized air to flow through the regulator. The maximum allowable air pressure through the regulator is determined by spring forces of the first and second springs and resistance of the piston to the flow of air through the valve.
Patent AU-2017381501-B2 (AU)
Title: Food and beverages containing cyclo(aspartyl-glycine), glucose, and maltose
Inventor: YAMAMOTO KENJI
IPC: C07K5/12
Filed: 2017-12-18
Granted: 2022-02-24
Abstract: The present invention provides food and beverages which have good flavor as a result of reducing an astringent taste caused by cyclo(aspartyl-glycine) contained therein. According to the present invention, both the cyclo(aspartyl-glycine) content in the food and beverages and the weight ratio (glucose/maltose weight ratio) of the glucose content to the maltose content are adjusted so as to fall within specific ranges.
Patent AU-2017387695-B2 (AU)
Title: (Aza)indole-, benzothiophene-, and benzofuran-3-sulfonamides
Inventor: MUELLER CHRISTA E
IPC: A61P25/18
Filed: 2017-12-27
Granted: 2022-06-23
Abstract: Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.
Patent AU-2017387790-B2 (AU)
Title: System and methods for detecting vehicle braking events using data from fused sensors in mobile devices
Inventor: SNYDER JARED S
IPC: B60Q1/52
Filed: 2017-12-08
Granted: 2020-03-12
Abstract: One or more braking event detection computing devices and methods are disclosed herein based on fused sensor data collected during a window of time from various sensors of a mobile device found within an interior of a vehicle. The various sensors of the mobile device may include a GPS receiver, an accelerometer, a gyroscope, a microphone, a camera, and a magnetometer. Data from vehicle sensors and other external systems may also be used. The braking event detection computing devices may adjust the polling frequency of the GPS receiver of the mobile device to capture non-consecutive data points based on the speed of the vehicle, the battery status of the mobile device, traffic-related information, and weather- related information. The braking event detection computing devices may use classification machine learning algorithms on the fused sensor data to determine whether or not to classify a window of time as a braking event.
Patent AU-2017429029-B2 (AU)
Title: Wall unit, assembly-type wall and method for installing same
Inventor: HE LIANG
IPC: E04B2/82
Filed: 2017-10-13
Granted: 2020-09-10
Abstract: Disclosed is an assembly-type wall, comprising a first wall unit (1) and a second wall unit (2), wherein a first end of the first wall unit (1) is used for connecting to a house structure wall (3) at a first end of the assembly-type wall, a second end of the first wall unit (1) is connected to a first end of the second wall unit (2), and a second end of the second wall unit (2) is connected to a house structure wall (4) at a second end of the assembly-type wall; the second wall unit (2) comprises a fixed wall mechanism (21) and a slidable wall mechanism (22), and a first end of the fixed wall mechanism (21) is connected to the second end of the first wall unit (1); an inner side of the fixed wall mechanism (21) is provided with a sliding rail (211), the slidable wall mechanism (22) is provided on the sliding rail (211), and the sliding direction of the sliding rail (211) is parallel with the wall direction of the fixed wall mechanism (21); and an inner side of the slidable wall mechanism (22) is provided with a telescopic support rod (221) used for adjusting the thickness of the slidable wall mechanism (22).The assembly-type wall can realise wall installation in non-standard sized spaces, thereby increasing installation efficiency and reducing labour intensity and noise pollution.
Patent AU-2018201534-B2 (AU)
Title: Molecules with reduced effector function and extended half-lives, compositions, and uses thereof
Inventor: TSUI PING
IPC: A61K39/395
Filed: 2018-03-02
Granted: 2020-01-02
Abstract: Provided are polypeptides comprising a variant IgG Fe domain, wherein the polypeptides exhibit reduced or ablated effector functions (e.g., ADCC and/or CDC) and increased stability and plasma half-life compared to a parent polypeptide. Also provided are compositions, methods of treatment, and methods to diminish Fc-induced effector function in a parent polypeptide.
Patent AU-2018204762-B2 (AU)
Title: Electrolyzer and membranes
Inventor: MASEL RICH
IPC: C02F1/461
Filed: 2018-06-29
Granted: 2019-11-21
Abstract: ELECTROLYZER AND MEMBRANES An electrochemical device converts C02 into various products such as CO, HCO-, H2CO, (HCO2 )-, H2CO2 , CH30H, CH4 , C2H 4, CH3CH2OH, CH3COO, CH3COOH, C2H6 , (COOH) 2, (COO-) 2 , H2C=CHCOOH, and CF3COOH. The device is made up of an anode, a cathode, and a Helper Membrane. In some embodiments, the device can also contain a catalytically active element. In some embodiments, the device is able to achieve a faradaic efficiency above 50% and C02 conversion current density over 20 mA/cm2 at a cell voltage of 3.0 V. In some embodiments, the Helper Membrane comprises a polymer containing an imidazolium ligand, a pyridinium ligand, or a phosphonium ligand.
Patent AU-2018210336-B2 (AU)
Title: Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves
Inventor: CHAMBERS JEFFREY W
IPC: A61F2/24
Filed: 2018-01-19
Granted: 2019-09-12
Abstract: Embodiments of delivery systems, devices and methods for delivering a prosthetic heart valve device to a heart chamber for expanded implementation are disclosed. More specifically, methods, systems and devices are disclosed for delivering a self-expanding prosthetic mitral valve device to the left atrium, with no engagement of the left ventricle, the native mitral valve leaflets or the annular tissue downstream of the upper annular surface during delivery, and in some embodiments with no engagement of the ventricle, mitral valve leaflets and/or annular tissue located downstream of the upper annular surface by the delivered, positioned and expanded prosthetic mitral valve device.
Patent AU-2018232926-B2 (AU)
Title: Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof
Inventor: SMITH ERIC
IPC: C07K16/28
Filed: 2018-09-18
Granted: 2020-06-25
Abstract: The present invention provides antibodies that bind to CD3 and methods of using the same. According to certain embodiments, the antibodies of the invention bind human CD3 with high affinity and induce human T cell proliferation. The invention includes antibodies that bind CD3 and induce T cell-mediated killing of tumor cells. According to certain embodiments, the present invention provides bispecific antigen-binding molecules comprising a first antigen-binding domain that specifically binds human CD3, and a second antigen-binding molecule that specifically binds human CD20. In certain embodiments, the bispecific antigen-binding molecules of the present invention are capable of inhibiting the growth of B-cell tumors expressing CD20. The antibodies and bispecific antigen-binding molecules of the invention are useful for the treatment of diseases and disorders in which an upregulated or induced targeted immune response is desired and/or therapeutically beneficial. For example, the antibodies of the invention are useful for the treatment of various cancers as well as other CD20-related diseases and disorders.
Patent AU-2018278184-B2 (AU)
Title: Coupling devices for surgical instruments and related methods
Inventor: LINDENMANN PHILIPPE
IPC: A61B90/00
Filed: 2018-05-30
Granted: 2020-12-10
Abstract: Coupling devices and related methods are disclosed herein, e.g., for coupling a surgical instrument to a navigation array or other component. The coupling device can reduce or eliminate movement between the instrument and the navigation array, improving navigation precision. The coupling device can be quick and easy to use, reducing or eliminating the need for extra steps or additional tools to attach or detach the instrument from the coupling device. In some embodiments, the single step of inserting an instrument into the coupling device can automatically lock the instrument within the coupling device in a toggle-free manner. The coupling device can include features for consistently attaching instruments thereto at a known or predetermined location and/or orientation.
Patent AU-2018284134-B2 (AU)
Title: Downhole power source
Inventor: HUNTER JOHN
IPC: E21B41/00
Filed: 2018-06-14
Granted: 2023-06-15
Abstract: A power source system comprising a plurality of cells. The power source system uses electrical charge or current generated by a reaction in at least one of the cells to provide at least one operating material to at least one other of the cells. Optionally, the power source system uses the electrical charge generated by the reaction in the at least one of the cells to provide the at least one operating material to the at least one other of the cells only when the state of charge of the at least one of the cells is equal to or below a threshold or when the use of the cell is equal to or above a threshold. Optionally, in an initial or non-operational state, oneor more or each of the cells is dry or without the at least one operating material and the power source system is configured to selectively switch at least one of the plurality of cellsfrom the non- operational state to an operational stateby providing the at least one operating material to the at least one cell.
Patent AU-2018340299-B2 (AU)
Title: Method for the preparation of chiral alpha haloalkanoic acids
Inventor: SPELBERG MARKUS
IPC: C12P7/40
Filed: 2018-09-24
Granted: 2023-10-19
Abstract: What is described herein relates to a method of selectively hydrolyzing an enantiomer of an alpha haloalkanoic acid according to formula I employing a polypeptide having dehalogenase activity comprising an amino acid sequence as set forth in SEQ ID NO. 1 or SEQ ID NO. 4 or a sequence with at least 80% sequence identity to either of said sequences and to the use of said method.